Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to KZR Stock Lookup

(KZR) – Hot FDA News

Jun 27, 2022 04:02 PM Kezar Life Sciences (KZR) Announces Positive Topline Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib for the Treatment of Patients with Lupus Nephritis
Nov 15, 2021 04:48 PM Kezar Life Sciences (KZR) Climbs 47% Following Interim Results from the MISSION Phase 2 Trial

Back to KZR Stock Lookup